• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Cellular mechanisms of tumor rejection in vivo and enhanced induction of anti tumor protective immunity applicable to tumor-specific immunotherapy.

作者信息

Fujiwara H, Hamaoka T

出版信息

Prog Exp Tumor Res. 1988;32:69-103. doi: 10.1159/000414674.

DOI:10.1159/000414674
PMID:2967523
Abstract
摘要

相似文献

1
Cellular mechanisms of tumor rejection in vivo and enhanced induction of anti tumor protective immunity applicable to tumor-specific immunotherapy.体内肿瘤排斥的细胞机制以及适用于肿瘤特异性免疫治疗的抗肿瘤保护性免疫的增强诱导。
Prog Exp Tumor Res. 1988;32:69-103. doi: 10.1159/000414674.
2
The augmentation of tumor-specific immunity by virus help. III. Enhanced generation of tumor-specific Lyt-1+2- T cells is responsible for augmented tumor immunity in vivo.病毒辅助增强肿瘤特异性免疫。III. 肿瘤特异性Lyt-1+2- T细胞生成的增强是体内肿瘤免疫增强的原因。
Cancer Immunol Immunother. 1986;21(3):193-8. doi: 10.1007/BF00199361.
3
Establishment of tumor-specific immunotherapy model utilizing vaccinia virus-reactive helper T cell activity.利用牛痘病毒反应性辅助性T细胞活性建立肿瘤特异性免疫治疗模型。
Eur J Immunol. 1988 Nov;18(11):1773-8. doi: 10.1002/eji.1830181118.
4
Tumor immunotherapy by local injection of interleukin 2 and non-reactive lymphocytes. Experimental and clinical results.通过局部注射白细胞介素2和无反应性淋巴细胞进行肿瘤免疫治疗。实验和临床结果。
Prog Exp Tumor Res. 1988;32:187-212. doi: 10.1159/000414679.
5
Tumor-specific immunotherapy by active immunization with haptenic muramyl dipeptide derivative-coupled tumor cells.通过用半抗原化的胞壁酰二肽衍生物偶联的肿瘤细胞进行主动免疫来进行肿瘤特异性免疫治疗。
Prog Clin Biol Res. 1987;244:335-44.
6
The role of tumor-specific Lyt-1+2- T cells in eradicating tumor cells in vivo. I. Lyt-1+2- T cells do not necessarily require recruitment of host's cytotoxic T cell precursors for implementation of in vivo immunity.肿瘤特异性Lyt-1⁺2⁻ T细胞在体内清除肿瘤细胞中的作用。I. Lyt-1⁺2⁻ T细胞在实施体内免疫时不一定需要募集宿主的细胞毒性T细胞前体。
J Immunol. 1984 Sep;133(3):1671-6.
7
Augmentation of antitumor immune response by trinitrophenyl (TNP)-reactive helper T-cells: enhanced induction of tumor-specific Lyt-1+2- T-cell-mediated delayed-type hypersensitivity from spleen cells of tumor-bearing mice by TNP helpers.三硝基苯基（TNP）反应性辅助性T细胞增强抗肿瘤免疫反应：TNP辅助细胞增强荷瘤小鼠脾细胞诱导肿瘤特异性Lyt-1+2- T细胞介导的迟发型超敏反应。
J Natl Cancer Inst. 1986 Dec;77(6):1267-72.
8
Genetic regulation of the antibody response to alloantigen Ly-6.2:2. Evidence for a suppressor mechanism.对同种异体抗原Ly-6.2:2抗体反应的遗传调控：2. 抑制机制的证据。
Transplant Proc. 1982 Dec;14(4):682-4.
9
Differential ability of tumor-unique and cross-reactive antigen(s) on two murine hepatoma cell lines to induce Lyt-1+2- T cells responsible for in vivo protective immunity.两种小鼠肝癌细胞系上肿瘤特异性和交叉反应性抗原诱导负责体内保护性免疫的Lyt-1+2-T细胞的差异能力。
Biken J. 1987 Mar;30(1):1-8.
10
T-cell responses induced by the parenteral injection of antigen-modified syngeneic cells. II. Mechanisms, specificity, and cellular analysis of 2,4,6-trinitrophenol (TNP)-specific cytolytic response priming by intravenous versus subcutaneous injection with TNP-modified syngeneic cells.经肠胃外注射抗原修饰的同基因细胞诱导的T细胞应答。II. 通过静脉注射与皮下注射三硝基苯酚（TNP）修饰的同基因细胞引发TNP特异性溶细胞应答的机制、特异性及细胞分析
Cell Immunol. 1983 Dec;82(2):378-93. doi: 10.1016/0008-8749(83)90171-5.

引用本文的文献

1
Therapeutic effect of a vaccinia colon oncolysate prepared with interleukin-2-gene encoded vaccinia virus studied in a syngeneic CC-36 murine colon hepatic metastasis model.在同基因CC-36小鼠结肠肝转移模型中研究用白细胞介素-2基因编码痘苗病毒制备的痘苗结肠溶瘤产物的治疗效果。
Cancer Immunol Immunother. 1994 Apr;38(4):259-64. doi: 10.1007/BF01533517.
2
Helper strategy in tumor immunology: expansion of helper lymphocytes and utilization of helper lymphokines for experimental and clinical immunotherapy.肿瘤免疫学中的辅助策略：辅助淋巴细胞的扩增及辅助淋巴因子在实验性和临床免疫治疗中的应用
Cancer Metastasis Rev. 1988 Dec;7(4):289-309. doi: 10.1007/BF00051371.
3
Tumor-immunotherapy with the use of tumor-antigen-pulsed antigen-presenting cells.
使用肿瘤抗原脉冲抗原呈递细胞进行肿瘤免疫治疗。
Cancer Immunol Immunother. 1992;35(1):1-6. doi: 10.1007/BF01741047.